Solutions for
BioPharma
Leverage customizable digital health solutions to provide patient heart rhythm data, anytime and anywhere
Providing specialized ECG-based digital health solutions to help our partners enable decentralized clinical trials, support digital health strategies, and remove barriers to prescribing medications that require cardiac monitoring.
R&D Solutions
Decentralized Clinical Trials
Capture critical heart rhythm data whenever you need it*
Our advanced digital health solutions allow us to partner with CROs and pharmaceutical clinical teams to enable patient-friendly remote ECG monitoring that supports Phase I–IV studies for decentralized clinical trials.
Leveraging KardiaMobile® 6L, the world's first FDA-cleared 6-lead personal ECG device, obtain objective measurement of cardiac safety signals, including atrial fibrillation, QT/QTc/QTcF**, bradycardia, tachycardia, sinus rhythm with SVE, sinus rhythm with PVCs and sinus rhythm with wide QRS.
Commercial Solutions
Cardiac Safety Monitoring (CSM)
Remove barriers to prescribing medications that impact heart rhythm
Certain medications can cause cardiac arrhythmias. For example, tyrosine kinase inhibitors (TKIs) are associated with atrial fibrillation, and sphingosine 1-phosphate (S1P) receptor modulators cause QT prolongation which can lead to dangerous arrhythmias. As a result, many healthcare professionals are wary of prescribing these medications, due to the burden associated with cardiac monitoring.
AliveCor BioPharma enables streamlined, reimbursable† in-office ECG screening that provides cardiac rhythm determinations — including atrial fibrillation, bradycardia, tachycardia, PVCs and more — in just 30 seconds.
Commercial Solutions
Drugs+ and Beyond the Pill Programs
Enhance your Rx brand with innovative digital health strategies
We partner with prescription brands to develop customized digital health solutions that include virtual cardiology and remote patient monitoring platforms. Our remote monitoring devices, apps, and solutions can be used for patient screening, disease monitoring, medication management and more.
Get started
Explore partnership opportunities with AliveCor BioPharma
KardiaMobile® 6L
The #1 doctor-recommended and patient-preferred 6-lead personal ECG, KardiaMobile 6L is FDA-cleared to provide medical-grade heart rhythm data, anytime and anywhere. With no wires, patches or gels, the device easily captures six leads of patient heart data, either remotely or onsite.
KardiaRx™
KardiaRx is an iOS/Android app which enables remote ECG capture and monitoring in decentralized clinical trials. When the app pairs with KardiaMobile 6L, patient ECGs are automatically uploaded to KardiaPro, our web-based portal, or another preferred EDC platform — for 24/7 access to critical cardiac rhythm data.
KardiaStation™
KardiaStation by AliveCor BioPharma allows healthcare professionals and clinical teams to record, store and review six leads of patient ECG data, right in their office, using KardiaMobile 6L. KardiaStation includes innovative technology called InstantQT™, which helps physicians more confidently prescribe QT-prolonging medications. InstantQT uses AliveCor’s FDA-cleared QT algorithm, which has been shown to accurately measure the QT interval.
KardiaPro®
Securely manage and review ECG data captured with KardiaMobile 6L on our HIPAA-compliant, SOC-2 certified, web-based portal.
Our Team
Our BioPharma management team offers over 70 years of combined experience in leading Top 10 Pharma & CRO companies. And our front- and back-end engineers have the technical expertise needed to help fully support our partners across any project.
David Zied
VP, Global BioPharma Partnerships
David is an experienced pharmaceutical executive with more than 25 years in sales, marketing and operational leadership roles with several of the world’s leading pharmaceutical companies, including GSK, BMS, Bayer and Eisai. After working across several therapeutic areas including neurology, mental illness, cardiology and 15+ years in oncology, David joined AliveCor from Novartis Oncology, where he was responsible for developing innovative digital solutions through strategic partnerships with startups, including AliveCor. As the VP of Global BioPharma Partnerships, David works closely with Pharma clients to develop and launch brand-focused digital solutions to enable brand growth and improve patient access worldwide.
Rob Kent
Senior Director, Business Development - Global CRO & Clinical Trials
Rob is a cardiology-focused nurse who has 30 years of experience in assisting pharmaceutical companies, medical device companies, CROs and government agencies collect and assess cardiovascular data from cardiology patients and medical trial participants. He has held business development and leadership roles at several global contract research organizations, including IQVIA and Premier Research. Rob is currently the Senior Director of Business Development at AliveCor BioPharma and is responsible for developing relationships with clients who want to utilize AliveCor’s innovative digital health solutions to both improve the conical trial participant experience and gather high-quality cardiovascular data from non-traditional clinical trial environments.
Arush Pandya
Senior Director, Global BioPharma Product Management
Arush is a Product Manager, innovator, and entrepreneur who is passionate about finding solutions to consumer-centric problems in the healthcare industry. He is currently the Senior Director of Product Management for Global BioPharma at AliveCor where he oversees development and implementation of technical solutions to enable cutting-edge ECG recording technologies for clinical trials, cardiac safety monitoring programs, and DTx programs. Arush has over 25 years of experience in the pharmaceutical industry.
Hager Elgedawe
Global Clinical Implementation Lead
Hager is a clinical research professional with over 10 years of experience running clinical trials in oncology, hematology, and cardiothoracic surgery at nationally renowned institutions including the Seattle Cancer Care Alliance, and Columbia University. She is currently the Global Clinical Implementation Lead at Alivecor, working with institutional and industry partners to utilize Alivecor’s innovative Kardiamobile 6L device in both clinical trials and post registration programs.
Partner with AliveCor BioPharma to benefit from our specialized ECG digital health solutions
Legal
*KardiaMobile 6L does not check for myocardial infarction (heart attack).
**QT/QTc/QTcF automated determinations made by AliveCor QT Service.
†AliveCor makes no guarantee, promise, or direct instruction regarding billing, coverage, or reimbursement. Accurate coding and claims submission practices are the sole responsibility of the health care provider.